Health

OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products

SHANGHAI, April 29, 2023 /PRNewswire/ -- On April 21, 2023, OBiO Technology ( Shanghai) Corp., Ltd. (OBiO) announced a strategic agreement of commercial manufacturing collaboration with CHINAGENE. Under the agreement, OBiO will provide holistic contract development and manufacturing services to CH...

2023-04-29 23:20 4252

ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars"

MSIDA, Malta, April 28, 2023 /PRNewswire/ -- Yesterday, the celebrations for the MALETH project took place with a special keynote presentation from Dr.James Green, NASA's Former Chief Scientist. From Singleron, Dr. Samuel Kerr joined to present the yeast research studies aboard the International ...

2023-04-28 20:56 2099

Engineering Biology Innovation Forum IV, Guangming Science City 2023SynBio China II and Asian Synthetic Biology Innovation Forum I Held in Shenzhen

SHENZHEN, China, April 28, 2023 /PRNewswire/ -- Engineering Biology Innovation Forum IV, Guangming Science City 2023SynBio China II and Asian Synthetic Biology Innovation Forum I were held inShenzhen on April 27th – 28th. The event assembled distinguished guests from political, industry, univers...

2023-04-28 20:36 3424

Cathay Life Celebrates Fifth Celent Model Insurer Award

Research and development of new risk control model attracts international attention TAIPEI, April 28, 2023 /PRNewswire/ -- Cathay Life Insurance has once again been recognized for its expertise, taking home the company's fifth Model Insurer Award from Celent, the global consulting and research c...

2023-04-28 19:45 5444

HanAll Biopharma Reports First Quarter Results and Provides Business Update

* Financial results for the first quarter ended with revenue of KRW 28.8 billion, up by 20 percent compared to the same period in 2022 * HanAll made a strong start to 2023 with positive Phase 3 study results of anti-FcRn asset batoclimab for the treatment of generalized myasthenia gravis in C...

2023-04-28 19:00 2901

IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study

SAN DIEGO, SHANGHAI and SYDNEY, April 28, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced positive topline results from a Phase 1 study evaluating IMG-004 in healthy participants. IMG-004 is a potent, non-covalent, reversible, and brain permeable third-generation Br...

2023-04-28 17:00 1831

Paying it forward: SM marks another year of positive community impact

PASAY CITY, Philippines, April 28, 2023 /PRNewswire/ -- Glenn Paul Añover Embodo is among the 'Yolanda' scholars helped by SM Foundation, Inc. of the SM Group, following the devastation of the super typhoon in the country in 2013.  More ...

2023-04-28 16:12 3310

FWD and SCB extend bancassurance partnership in Thailand

* New agreement extends long-term exclusive bancassurance partnership for a further two years * The partnership with SCB is the largest contributor to FWD Thailand's business BANGKOK, April 28, 2023 /PRNewswire/ -- FWD Life Insurance Public Company Limited ("FWD Thailand") and Siam Commercial...

2023-04-28 16:09 2852

United Imaging Healthcare delivers its first annual report since going public, with revenue growth of nearly 30% in 2022

Along with the publication of its 2022 annual report and its first quarter report for 2023, United Imaging Healthcare released its ESG report today. SHANGHAI, April 28, 2023 /PRNewswire/ -- United Imaging Healthcare achieved a YoY revenue growth of 27.36 %, a figure published in the company's 202...

2023-04-28 15:53 1763

WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability

* The Report outlines new goals of net-zero GHG emissions across all operations by 2050 and a 10% reduction of waste intensity by 2027 compared with 2022. * The Company makes remarkable progress on environmental goals, achieving its water consumption intensity-reduction target in 2022, well a...

2023-04-28 14:43 2895

Toshiba Announces the Commencement of Treatment Using Toshiba Heavy Ion Therapy System at the Yonsei University Health System

~First heavy ion treatment in Korea ~ KAWASAKI, Japan, April 28, 2023 /PRNewswire/ -- Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion therapy*1 system supplied by Toshiba ESS in collaboration ...

2023-04-28 12:00 3291

European Wellness Collaborates with Heidelberg University in Journal Publications of "Synergistic Anti-Ageing Through Senescent Cells Specific Reprogramming"

HEIDELBERG, Germany, April 28, 2023 /PRNewswire/ -- European Wellness Academy (EWA), an educational arm of European Wellness Biomedical Group (EW Group), has collaborated with Heidelberg University on journal publication. The research project, titled "Synergistic Anti-Ageing Through Senescent Cel...

2023-04-28 11:58 2739

HOYA Vision Care Elevates Children's Protection Against Myopia & Intensive Light With MiYOSMART Sun Lenses

SINGAPORE, April 28, 2023 /PRNewswire/ -- HOYA Vision Care , a leader in optical technology innovation, has launched MiYOSMART Sun spectacle lenses inSingapore, which are designed to be effective and non-invasive protection against myopia for children. The photochrom...

2023-04-28 11:18 2698

Brii Bio Publishes 2022 Environmental, Social and Governance Report

Brii Bio receives an "A" grade in the latest MSCI ESG Rating DURHAM, N.C. and BEIJING, April 28, 2023 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health ...

2023-04-28 09:00 2897

Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio

- Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech investment firm - Targeting the KRW 146 trillion global autoimmune disease market with partner who has top global drug development expertis...

2023-04-28 08:58 2073

OrthAlign's 50th Patent Affirms Position as A Global Leader in Surgical Navigation

ALISO VIEJO, Calif., April 28, 2023 /PRNewswire/ -- OrthAlign® Inc., a global leader in orthopedic surgical navigation technology, continues to expand its IP portfolio, with its 50th patent being issued. OrthAlign pioneered and continues to enhance surgical navigation solutions proven to enable a...

2023-04-28 04:33 2303

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...

2023-04-28 00:29 3037

Steakholder Foods® 3D Bio-Prints First Ready-to-Cook Cultivated Grouper Fish

Steakholder Foods 3D bio-printed the world's first cultivated fish fillet: * The Company has reached a significant milestone by successfully customizing bio-inks utilizing grouper cells provided by Umami Meats' to print a cultivated grouper product – a significant step towards the commercializa...

2023-04-27 23:50 4690

Ubie signs a broad collaboration agreement with Takeda Pharmaceuticals to promote digital transformation

- Aims to guide patients with rare and gastrointestinal diseases to appropriate medical care 〜Ubie will build on its achievements in the early detection of HAE and expand its collaboration with Takeda Pharmaceuticals to benefit patients in broader disease areas〜 NEW YORK, April 27, 2023 /PRNews...

2023-04-27 23:00 1852

Healint announces a collaboration with Saitama Medical University Hospital, Japan, to verify AI diagnosis of Migraine

PALO ALTO, Calif., April 27, 2023 /PRNewswire/ -- Saitama Medical University Hospital and Healint launched one of the world's first clinical studies titled "Verification of Headache AI diagnosis by using Electronic Headache Diary in Telemedicine". About 20 renowned headache specialists partici...

2023-04-27 21:15 1977
1 ... 234235236237238239240 ... 848